ライフサイエンスコーパス: vehicle

1 nd work-based PNEFs were calculated for each vehicle.

2 duction in the treated corneas compared with vehicle.

3 th both orchiectomy and ARN-509 but not with vehicle.

4 volunteers was stimulated with LPS, MPLA or vehicle.

5 od flow recovery compared with ECFC, MPC, or vehicle.

6 fluid stem cells in two different doses, and vehicle.

7 more EVs than cholangiocytes incubated with vehicle.

8 ed anchovies are recognised as the main food vehicle.

9 d-type (WT) and MCP-1(-/-) mice with hPTH or vehicle.

10 reated with the antipsychotic haloperidol or vehicle.

11 , indicating sea ice as a possible transport vehicle.

12 atment with ARN-509, orchiectomy, or control vehicle.

13 ue eosinophilia compared with mice receiving vehicle.

14 nd increasing sleep efficiency compared with vehicle.

15 an arteries were treated with tofacitinib or vehicle.

16 ecule (e.g., peptides and proteins) delivery vehicles.

17 wireless power transfer to moving devices or vehicles.

18 mbedded in other products, notably passenger vehicles.

19 hose of hybrid electric and battery electric vehicles.

20 emissions for two Euro 6 diesel and gasoline vehicles.

21 rs were investigated as aerosolized delivery vehicles.

22 captive-raised animals are fatally struck by vehicles.

23 or/generator embedded in hybrid and electric vehicles.

24 ural biomaterials as potential oral delivery vehicles.

25 hey have not yet been adopted for heavy-duty vehicles.

26 investigation as drug delivery and targeting vehicles.

27 y cycles required for start-stop microhybrid vehicles.

28 e-induced increased permeability compared to vehicle (0.1% ethanol).

29 s measured after subcutaneous injection with vehicle, 1 mg norepinephrine/kg, or 5 mg AITC/kg.

30 increase in energy expenditure compared with vehicle (17.5 +/- 4.9 J .

31 ons than GDIs certified as ultralow-emission vehicles (3.0 +/- 1.1 versus 6.3 +/- 1.1 mg/mi), suggest

32 inin-1 receptor antagonist survival = 79% vs vehicle = 54%).

33 n emergency department within 6 h of a motor vehicle accident.

34 Moreover, sleep deprivation brings about vehicle accidents and medical errors and is therefore an

35 ion studies include increased risk for motor vehicle accidents, psychotic symptoms, and short-term co

36 we compared the effects of kisspeptin versus vehicle administration in 29 healthy heterosexual young

37 tered a single dose of PERC (1,000 mg/kg) or vehicle (Alkamuls-EL620) and euthanized at various time

38 fibrosis observed in kidneys pretreated with vehicle alone.

39 +/- 1.6% vs. 21.3 +/- 1.5% of total cells in vehicle and 19.3 +/- 1.8% in RA CMCs; p < 0.05).

40 eloping synthetic vesicles as a new delivery vehicle and adjuvant for immunoprophylactic schistosomul

41 gh the prevalence of AAA was similar between vehicle and CAR-DCN groups, the severity of AAA in the C

42 FR at week 20 differed significantly between vehicle and LPAR inhibitor groups (P<0.05).

43 (200-350 degrees Celsius), so the focus for vehicle and portable PEMFC applications has been on aque

44 We present a new methodology using vehicle and powertrain parameters within a Bayesian fram

45 RNA-seq analysis of vehicle and STAT3 inhibitor treated K14CreERT;DLX3(fl/fl

46 he algorithm applies to fleets of autonomous vehicles and also incorporates rebalancing of idling veh

47 efficiently than internal combustion engine vehicles and do not require large plug-in batteries.

48 ing motor embedded in conventional passenger vehicles and drive motor/generator embedded in hybrid an

49 .S.-wide air quality impacts of electrifying vehicles and off-road equipment are estimated for 2030 u

50 methane emissions from HD natural gas fueled vehicles and the compressed natural gas (CNG) and liquef

51 sceptibility 2 weeks after TBI compared with vehicle, and a reduction in hippocampal astrogliosis.

52 om biomass burning, diesel vehicle, gasoline vehicle, and dust sources was similar in chemical compos

53 ue taxis-especially when in front of another vehicle, and in street lighting-other drivers can better

54 pancreatic islet cells, or mock-treated with vehicle, and maintained for 10 days before intravitreal

55 as drug and medical contrast agent delivery vehicles, and as biosensors and biofuel cells.

56 y, continuous manufacturing of drug delivery vehicles, and ultra-precise dosing of high potency drugs

57 gy density of lithium batteries for electric vehicle applications.

58 On-road gasoline vehicles are a major source of secondary organic aerosol

59 These new investment vehicles are more aligned with the geography and type of

60 ic hydrocarbons (p-PAHs) emitted from diesel vehicles are of concern because of their significant hea

61 Heavy-duty vehicles are the dominant contributor to excess diesel N

62 tion, mice received probiotic L. reuteri, or vehicle as a control, via oral gavage following each str

63 were treated with L. reuteri or treated with vehicle as a control.

64 poE(-/-) mice were treated daily with 15a or vehicle as control.

65 ation-based results with observed changes in vehicle attributes under the reformed standards.

66 nepafenac 0.3% ophthalmic suspension versus vehicle, based on clinical outcomes, after cataract surg

67 MAE) significantly increase loading on a per-vehicle basis as compared to antibody-drug conjugates (A

68 minergic cells, control cerebellar cells, or vehicle bilaterally and were studied for 18 months.

69 ith high potential as advanced drug delivery vehicles, bioreactors and artificial cells.

70 Gasoline- and diesel-powered motor vehicles, both on/off-road, are important sources of SOA

71 itor (2 mg/Kg/day) or the same volume of the vehicle by oral gavage.

72 erapy drugs and siRNA from a single delivery vehicle can have a significant impact on cancer therapy

73 om lightweighting internal combustion engine vehicles can be higher than those of hybrid electric and

74 ific targeting, thereby creating a molecular vehicle capable of delivering therapeutic cargo into the

75 dihydrotestosterone (CD-DHT, HF/HS-DHT) or a vehicle (CD-Veh, HF/HS-Veh).

76 For vehicles certified to the same emissions standard, there

77 Mean risk of pedestrian-vehicle collision in specific walking locations was asse

78 d as mean exposure to the risk of pedestrian-vehicle collision.

79 f the historical probabilities of pedestrian-vehicle collisions for intersections and midblock segmen

80 decision-makers additional insight into the vehicle content of strategic and minor metals of current

81 o apply topical fluorouracil, 5%, cream or a vehicle control cream to the face and ears twice daily f

82 Relative to the vehicle control group, mice receiving corticosterone had

83 in a lower median disease burden compared to vehicle control in all tissues analyzed, similar to the

84 high-fat diet were orally administered with vehicle control or UFP (40 mug/mouse/day) for 3 days a w

85 tion, whereas 100% of the mice receiving the vehicle control remained normoglycemic.

86 ncreased in (+)-JQ1 treated mice compared to vehicle control, similar to the original study.

87 mice in the corticosterone group relative to vehicle control.

88 d with penicillin-streptomycin (PenStrep) or vehicle control.

89 r 4T1 tumors compared to 67NR tumors and the vehicle control.

90 sulted in decreased tumor volume compared to vehicle control; however, while the effect was in the sa

91 tive COX-2 inhibitor parecoxib (25 mg/kg) or vehicle (control) for 7 and 28 days.

92 itor to reduce visceral hypersensitivity, or vehicle (control).

93 cted with TNF (5 mug/mouse for 3-6 hours) or vehicle (control); intestines were collected and analyze

94 mean 92.2% (range, 86.0%-99.4%) reduction vs vehicle controls (P < .0001) and in prolonged animal sur

95 often persists into adolescence, when motor vehicle crash risk peaks.

96 Motor vehicle crashes (MVCs) are a major public health problem

97 (3) Motor vehicle crashes and falls were the 2 leading causes of T

98 TBI deaths from motor vehicle crashes in children aged 0-14 years and adults a

99 Examples of these in the domain of motor vehicle crashes include policy change and enforcement of

100 ure, mortality, cardiovascular events, motor vehicle crashes, quality of life, and harms.

101 bis-related emergency room visits, and fatal vehicle crashes.

102 Chassis model year 2008 and 2009 vehicles currently dominate the fleet, accounting for th

103 Yet, various consumer devices and electric vehicles demand higher specific energy and power with lo

104 ost-GSK1265744 LAP administration, while the Vehicle depot did not suggesting that the active drug su

105 ice, while post-pubertal peritoneal cells or vehicle did not.

106 Compared with gasoline vehicles, diesel vehicles equipped with catalyzed or add

107 As the vehicles drift with the ambient flow or execute preprogr

108 ervations were recorded by remotely operated vehicles during surveys off the California Coast, from t

109 particle phase) to similar measurements from vehicle dynamometer tests, cooking emissions, biomass bu

110 gies for future CM quantities in end-of-life vehicles (ELVs) are poorly understood, mainly due to a l

111 s in anthropogenic emissions, primarily from vehicle emissions and residential fuel burning.

112 lts suggest that in addition to BB, gasoline vehicle emissions may also be an important BrC source in

113 expansion which predicted a 15%+ decrease in vehicle emissions on Saturdays.

114 gical complications of prolonged exposure to vehicle emissions remain unknown.

115 d that prolonged exposure to pro-oxidants in vehicle emissions result in behavioral and cognitive def

116 om prescribed and laboratory BB and gasoline vehicle emissions was examined using spectrophotometry.

117 easurements that help to guide regulation of vehicle emissions.

118 rs is derived from both industrial and motor vehicle emissions.

119 ants are considered as major constituents of vehicle emissions.

120 progressively tightened, but current diesel vehicles emit far more NOx under real-world operating co

121 e dipropionate, clobetasol propionate, and a vehicle/emollient control.

122 mined the make, model, and year of all motor vehicles encountered in particular neighborhoods.

123 Compared with gasoline vehicles, diesel vehicles equipped with catalyzed or additive DPF emit fe

124 increased the SOA yield from dilute gasoline vehicle exhaust by a factor of 8.

125 s and aftertreatment technologies may affect vehicle exhaust emissions.

126 The model used a simulated mixture of vehicle exhaust that comprised of pro-oxidant constituen

127 ingly attributable to a growing and outdated vehicle fleet and to famously congested roads.

128 on measurements on two California heavy-duty vehicle fleets.

129 p approaches used to estimate SOA from motor vehicles, focusing on inconsistencies between molecular-

130 1) mice were injected with THC (10 mg/kg) or vehicle for 10 days during mid-adolescence-equivalent pe

131 rats treated with RVXB (20 mg/kg/day) or its vehicle for 2 weeks.

132 oinformatics methods hold great promise as a vehicle for capitalizing on the explosion of data emanat

133 Antheraea mylitta serves as a delivery vehicle for cells.

134 geometric frustration can be exploited as a vehicle for conductivity tuning.

135 that BoNT/C1 ad can be useful as a molecular vehicle for drug delivery to the neuronal cytoplasm.

136 nmyelinated fibers may represent a potential vehicle for focal ictogenesis.SIGNIFICANCE STATEMENT We

137 t is a low-moisture food, raw flour can be a vehicle for foodborne pathogens.

138 ey show that exosomes can constitute a novel vehicle for haptenated proteins, and raise the hypothesi

139 fied with a polyoxazoline as a drug delivery vehicle for improving the therapeutic index of SN-38, th

140 ty to exploit the lymphatic circulation as a vehicle for metastasis and access to the lungs, and dest

141 s (CHP) have been demonstrated as a powerful vehicle for targeting denatured collagen (dColl) produce

142 rouracil (5-FU), were assessed as a delivery vehicle for the targeted treatment of pancreatic cancer

143 for 15 weeks and then treated with LH-21 or vehicle for two weeks.

144 e, genetically modified bacteria as delivery vehicles for biologics is of considerable interest scien

145 praying, were developed and used as delivery vehicles for curcumin.

146 to promote oxidative stability, allowing new vehicles for the application of these compounds in food

147 Compared with vehicle, FPS-ZM1 inhibited primary tumor growth, inhibit

148 Mice were treated with vehicle, FTY720, AAL(S) , BORT or AAL(S) +BORT and hallm

149 Battery electric vehicle fuel savings enable reduction of battery size wi

150 ound that PM2.5 from biomass burning, diesel vehicle, gasoline vehicle, and dust sources was similar

151 er in laropiprant group as compared with the vehicle group.

152 tteries in portable electronics and electric vehicles has spurred intensive research efforts over the

153 Particle emissions from heavy-duty vehicles (HDVs) have significant environmental and publi

154 four pesticide treatments (control, ethanol vehicle, herbicide mixture, and insecticide mixture) for

155 Maps, we investigated whether high-occupancy vehicle (HOV) policies can combat congestion.

156 the policy reduced fears of deportation and vehicle impoundment.

157 ework to determine the impact of engineering vehicle improvements on fuel consumption and CO2 emissio

158 reated with either Meth (1.2 mg/kg, i.p.) or vehicle in association, dissociation, or absence of an R

159 nzymes involved in ureagenesis compared with vehicle in C57Bl/6 mice.

160 g platform, or a drug targeting and delivery vehicle in general, is undermined by the fluidic and lab

161 gomers as an injectable therapeutic delivery vehicle in mice.

162 the clinical benefits of nepafenac 0.3% over vehicle in reducing the risk of postoperative ME, with t

163 patients treated with nepafenac 0.3% versus vehicle in study 1 and similar percentage in study 2 had

164 ion, animals were infused with either B/M or vehicle in the PL and tested in the acquisition context

165 Following infusions of B/M or vehicle in the PL, responding was tested in Context C an

166 centrations from a fleet of on-road gasoline vehicles in a smog chamber.

167 rities with human-engineered unmanned aerial vehicles in terms of overall autonomy, maneuverability,

168 In vehicles in use, we calculated 5-2(+3) t precious metals

169 1265744 LAP injected gastrocnemius while the Vehicle injected gastrocnemius appeared to show reduced

170 Compared with vehicle-injected mice, both iPSC- and iPSC-EV-treated mi

171 s in ECFC + MPC-injected muscles compared to vehicle-injected muscles.

172 rahydrocannabinol occluded LTD compared with vehicle injections; however, a single exposure was insuf

173 ansport of agents released from a coacervate vehicle into artificial sebum and the coacervate's compo

174 troducing inexpensive and efficient electric vehicles into the US light duty vehicle (LDV) sector.

175 The coacervate delivery vehicle is a simple and effective tool to improve the th

176 ete Freund's adjuvant (IFA) as a co-delivery vehicle, it was discovered that the controlled release o

177 ign a family of HP-beta-CD pro-drug delivery vehicles, known as polyrotaxanes (PR), capable of increa

178 ent electric vehicles into the US light duty vehicle (LDV) sector.

179 ined with a material flow analysis along the vehicle lifecycle in Switzerland to quantify the stocks

180 ion of the total unified cycle emissions for vehicles meeting more-stringent emission standards.

181 ately 17% of light duty and 8% of heavy duty vehicle miles traveled and from 17% to 79% of various of

182 e efficacy data emphasis on how the delivery vehicle modifies and enhances the accumulation of the dr

183 10), whereas control mice were injected with vehicle (n = 10).

184 S-492429 (30 mg/kg, twice a day) (n = 11) or vehicle (n = 12) from 1 hour before transplantation unti

185 rated mice (n = 10), MCAO mice receiving the vehicle (n = 15) and MCAO mice receiving an anti-myostat

186 on (Nx), being divided into: Nx+V, receiving vehicle, Nx+Eple, given eplerenone, 150 mg/kg/day, and N

187 when they were divided into: Nx+V receiving vehicle; Nx+L treated with losartan, 50 mg/kg/day; Nx+L+

188 ting perspectives for their potential use as vehicles of bioactive compounds as food additives or pha

189 d varying abilities of the sources to act as vehicles of infection.

190 Exosomes are important vehicles of intercellular communication that shape host

191 verely impairs their application as delivery vehicles of large drugs or as matrices for guiding prote

192 titative data essential to understanding the vehicles of spread and the ability of both species to su

193 andomized (1:1) to topical nepafenac 0.3% or vehicle once-daily starting the day before surgery and c

194 Wild-type (WT) and TG mice received vehicle or BACE inhibitor (60 mg/kg) starting at 7 wk of

195 beta-cells compared with those treated with vehicle or low-dose BRD3308.

196 Notably, compared with administration of vehicle or mutant inactive peptide, administration of th

197 lls into 14 female nude mice, treatment with vehicle or pazopanib (2.5 mg per mouse peroral every oth

198 differentiation versus minimal changes with vehicle or pimecrolimus (P < .001).

199 implanted with osmotic minipumps delivering vehicle or serelaxin for another 4 weeks.

200 ined leukemia progression in the presence of vehicle or tamoxifen.

201 iography, and rats were randomly assigned to vehicle or treatment (both n=12).

202 sampling was acquired from rats treated with vehicle or various concentrations of estradiol (nonspeci

203 Animals were pretreated with vehicle or ZA for a week, and EP was induced.

204 ection spread due to contaminated equipment, vehicles, or personnel proved to be important for severa

205 red in vitro All metabolic tissues tested in vehicle- or BRD3308-treated groups showed virtually no s

206 sion of road networks and surges in personal vehicle ownership are having profound effects on public

207 AAR1 partial agonist RO5263397, caffeine, or vehicle p.o.

208 mean 66.9% (range, 42.0%-87.6%) reduction vs vehicle (P < .0001).

209 Our results show how design changes in vehicle parameters (e.g., mass, engine size, and compres

210 ar seat and booster seat use for child motor vehicle passengers, speed limit and drunk driving laws,

211 the benefits of lightweighting depend on the vehicle powertrain.

212 rative hematoma volumes compared to those of vehicle preconditioned SBI animals.

213 On-road diesel vehicles produce approximately 20 per cent of global ant

214 -phase emissions from 82 light-duty gasoline vehicles recruited from the California in-use fleet test

215 However, if the grid decarbonizes, electric vehicles reduce emissions by 45 +/- 9% with further redu

216 Increasing plug-in and all-electric vehicles reduced CO2 emissions by less (42 +/- 10% reduc

217 The effects of vehicle-related emissions on health has been a long-stan

218 ission factors of priority p-PAHs for diesel vehicles representative of an array of emission control

219 local delivery of 2-PMPA in hypotonic enema vehicle resulted in prolonged drug concentrations for at

220 desirable for applications in the hypersonic vehicle, rockets, re-entry spacecraft and defence sector

221 the DREADD ligand clozapine-N-oxide (CNO) or vehicle (saline).

222 ent groups of rats that were pretreated with vehicle solution, a PAC1 receptor antagonist (experiment

223 degrees C, which was commonly achieved when vehicle speed sustained over 45 mph.

224 ing automaker responses to recently reformed vehicle standards with and without the ability to adjust

225 ays after surgery with nepafenac 0.3% versus vehicle (study 1: 2.3% vs. 17.3%; P < 0.001; study 2: 5.

226 s that mimic or inhibit miRNA function using vehicles such as cell penetrating peptides, spherical nu

227 perational costs for low- to medium-capacity vehicles, such as taxis and van shuttles.

228 Vehicle tailpipe and crankcase emissions were the highes

229 power, and LMA in all strains compared with vehicle; this effect was attenuated in KO and potentiate

230 an intravitreal injection of Edn2 or control vehicle to examine the blood pressure-independent effect

231 se integrated multi-omic analyses provided a vehicle to gain an in-depth knowledge of genome-metaboli

232 here represents a highly efficient delivery vehicle to hepatocytes.

233 a polymeric nanoparticle pesticide delivery vehicle to soybeans, zein nanoparticle (ZNP) uptake by t

234 and also incorporates rebalancing of idling vehicles to areas of high demand.

235 s, in many cases relying heavily on delivery vehicles to introduce them into cells and achieve their

236 have applications as selective drug delivery vehicles to tumours with the potential to decrease chemo

237 delivery of 2-PMPA, we studied the effect of vehicle tonicity on the absorption of 2-PMPA in the colo

238 rdiac myocytes was increased in CBSC- versus vehicle- treated animals.

239 pothermia and bacterial titers compared with vehicle-treated cecal ligation and puncture mice that su

240 enosine levels in treated mice compared with vehicle-treated controls.

241 oth wounded and unwounded eyes compared with vehicle-treated corneas.

242 ecular bone revealed that, compared with the vehicle-treated group, the PTH-treated WT mice had reduc

243 In the vehicle-treated groups, no significant change in TBR, K1

244 unctional photoreceptor rescue compared with vehicle-treated littermate control mice.

245 , lean mass and grip strength by 60-80% over vehicle-treated mdx mice.

246 2, increased anastomotic leakage compared to vehicle-treated mice (100% vs 25%, respectively).

247 ed exercise performance by 82% compared with vehicle-treated mice (P = 0.01).

248 ubular damage in mice with IRI compared with vehicle-treated mice with IRI.

249 lso prevented the decline in GFR observed in vehicle-treated mice, such that GFR at week 20 differed

250 th and better bone microarchitecture than in vehicle-treated mice.

251 fibrosis at 4 weeks post-IRI, compared with vehicle-treated mice.

252 ammatory infiltrates, compared with those in vehicle-treated mice.

253 her (cortical) bone formation as compared to vehicle-treated mice.

254 MC group (31.2 +/- 1.0% vs. 24.7 +/- 2.2% in vehicle-treated mice; p < 0.05) but not in the RA CMC gr

255 n SA CMCs (7.6 +/- 1.5% vs. 14.5 +/- 2.8% in vehicle-treated mice; p < 0.05) but not RA CMCs (11.7 +/

256 Intact trabeculae from vehicle-treated mutants displayed inotropic insufficienc

257 Compared with vehicle-treated proteinuric rats, paricalcitol showed ma

258 For each tracer, half the animals were vehicle-treated whereas the other half were pretreated w

259 f oral CRMP (2 mg/kg body weight per day) or vehicle treatment, mice underwent hyperinsulinemic-eugly

260 both tumor types and after GLS inhibitor or vehicle treatment, we observed a strong positive correla

261 ed polyposis by more than half compared with vehicle treatment.

262 01 for responding cell lines), compared with vehicle treatment.

263 In contrast to unconjugated D2B or vehicle, treatment with either of the MMAE-based ADCs, b

264 injected intravenously with Cyclo/Dox or the vehicle two hours after lights on (zeitgeber time (ZT2),

265 ted with carbon tetrachloride (CCl4) or with vehicle two times a week for 10 weeks and were imaged wi

266 The effect of vehicle type (eg, ointment, lotion, cream, butter) was a

267 However, the relative importance of each vehicle type with respect to SOA formation remains uncle

268 ecious metals in controllers embedded in all vehicle types and 220-60(+90) t rare earth elements (REE

269 ground receiver via a moving unmanned-aerial-vehicle (UAV).

270 amples include solar powered unmanned aerial vehicles (UAVs) and data storage servers.

271 Unmanned aerial vehicles (UAVs) provide an opportunity to rapidly census

272 controlled aerial drones (or unmanned aerial vehicles; UAVs) are employed for surveillance by the mil

273 d with artesunate (2.4 or 4.8 mg/kg i.v.) or vehicle upon resuscitation.

274 ce suggests that urban form can affect motor vehicle usage, a major contributor to urban air pollutio

275 Hybrid electric vehicles use gasoline more efficiently than internal com

276 of automakers to improve the fuel economy of vehicles using engineering design modifications that com

277 Significant differences versus vehicle values were limited to steroids (P < .0001).

278 ls randomly received either palm oil (PO) or vehicle (VCL).

279 Mice were vehicle (Veh, satellite cell-replete) or tamoxifen (Tam,

280 d either leptin (0.36 mg kg(-1) day(-1) ) or vehicle via osmotic minipumps for 3 weeks.

281 ed through day 90 with nepafenac 0.3% versus vehicle was 61.7% versus 43.0% (P < 0.001) in study 1, 4

282 CBD or vehicle was administered daily throughout the alcohol fe

283 er 75 days of E2 exposure, ETA antagonist or vehicle was administered i.c.v.

284 Lipopolysaccharide (LPS) or vehicle was administered peripherally to adult zebra fin

285 ) (wortmannin) was administered, and EX-4 or vehicle was administered via intraperitoneal (IP) inject

286 9cRA or vehicle was given via an intranasal route daily starting

287 RO5166017 (1.5 or 5.0 mug/side) or vehicle was microinjected into each brain region immedia

288 One vehicle was tested over the Federal Test Procedure (FTP)

289 fluid stem cells in two different doses, or vehicle were injected intraarterially.

290 Both vehicles were exercised over double Environmental Protec

291 The most popular vehicles were lotions (102 [59%]), followed by creams (2

292 The vehicles were tested on a chassis dynamometer under vari

293 sis of antibody-functionalized drug delivery vehicles, which were benchmarked against appropriate con

294 ion emissions from a growing fleet of diesel vehicles will be important.

295 We equipped Google Street View vehicles with a fast-response pollution measurement plat

296 n combination its use as functional delivery vehicles with antiretroviral therapy (ART).

297 and ownership cost impacts of lightweighting vehicles with different powertrains is reviewed.

298 Vehicles with lower powertrain efficiencies have higher

299 For vehicles with OEM DPFs and Selective Catalytic Reduction

300 ased fraction of pre-2008 chassis model year vehicles with retrofit diesel particulate filters (DPFs)